申请人:YAMANOUCHI PHARMACEUTICAL CO. LTD.
公开号:EP1557411A1
公开(公告)日:2005-07-27
The present invention relates to a novel N-phenyl-(2R,5S)dimethylpiperazine derivatives useful as antiandrogenic agent which exhibits a sufficient prostate gland reducing effect as compared with conventional compounds and are excellent in oral activity. The compound of the present application is useful in preventing or treating prostate cancer, benign prostatic hyperplasia, and the like. The present invention also provides a novel intermediate useful in producing the compound of the present invention.
本发明涉及一种新型 N-苯基-(2R,5S)二甲基哌嗪衍生物,可用作抗雄激素制剂,与传统化合物相比,该衍生物具有足够的前列腺抑制作用,且口服活性极佳。本申请的化合物可用于预防或治疗前列腺癌、良性前列腺增生症等。本发明还提供了一种可用于生产本发明化合物的新型中间体。